1. (1) The department incorporates by reference the IDSA/ATS/CDC treatment standards as described in the segment entitled:

   1. (a) Official ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, published by the Infectious Diseases Society of America (IDSA) in August 2016;
   2. (b) Treatment of Tuberculosis, American Thoracic Society, CDC, and Infectious Diseases Society of America, published by the CDC in June 2003;
   3. (c) Controlling Tuberculosis in the United States: Recommendations from the American Thoracic Society; CDC, and the Infectious Diseases Society of America, published by the CDC in November 2005; and
   4. (d) Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, published by the CDC in June 2000.
2. (2) A health-care provider who treats an individual with tuberculosis disease shall use the IDSA/ATS/CDC treatment standards as a reference for the development of a comprehensive treatment and follow-up plan for each individual. The plan shall be developed in cooperation with the individual and approved by the local health department or the program. Health-care providers shall routinely document an individual's adherence to prescribed therapy for tuberculosis infection and disease. If isolation is indicated, the plan for isolation shall be approved by the local health department or the program. Discharge from an inpatient facility shall not occur without the knowledge of, and in agreement with the local health department and the program.
3. (3) A health-care provider who treats an individual with suspect or active tuberculosis disease shall provide for directly observed therapy.
4. (4) Individuals with infectious tuberculosis disease shall comply with the treatment plan as set forth by the provider and public health, including isolation if necessary, wearing a mask approved by the local health department or the program when outside the isolation area, abiding by a plan of directly observed therapy, providing laboratory samples, and attending each scheduled provider visit.
5. (5) Any individual who does not comply with Subsection R388-804-6(4) shall be subject to involuntary isolation as established in the Title 26B, Chapter 7, Part 3, Treatment, Isolation, and Quarantine Procedures for Communicable Diseases.

KEY: tuberculosis, screening, communicable diseases

Date of Last Change: November 8, 2024

Notice of Continuation: May 7, 2026

Authorizing, and Implemented or Interpreted Law: 26B-7-206 through 26B-7-209; 26B-7-303 through 26B-7-315; 26B-7-3